XML 16 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 01, 2016
Oct. 03, 2015
Cash flows from operating activities:    
Net income/(loss) $ 65,544 $ (596)
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 212,440 199,970
Loss on disposal of property, plant, equipment and other assets 873 627
Gain on insurance proceeds from insurance settlements (356) (561)
Deferred taxes (5,223) 8,640
Increase/(decrease) in long-term pension liability (1,105) 678
Stock-based compensation expense 7,953 6,468
Write-off deferred loan costs 292 10,633
Deferred loan cost amortization 8,393 7,380
Equity in net loss/(income) of unconsolidated subsidiaries (37,633) 9,657
Proceeds from Equity Method Investment, Dividends or Distributions 26,317 26,155
Changes in operating assets and liabilities, net of effects from acquisitions:    
Accounts receivable (3,058) 7,658
Income taxes refundable/payable 1,432 3,955
Inventories and prepaid expenses (11,368) 7,667
Accounts payable and accrued expenses 27,438 (10,318)
Other (11,377) 18,641
Net cash provided by operating activities 280,562 296,654
Cash flows from investing activities:    
Capital expenditures (168,224) (162,264)
Acquisitions, net of cash acquired (8,511) 0
Gross proceeds from disposal of property, plant and equipment and other assets 4,492 2,473
Proceeds from insurance settlement 1,537 561
Payments related to routes and other intangibles 0 (2,939)
Net cash used by investing activities (170,706) (162,169)
Cash flows from financing activities:    
Proceeds from long-term debt 28,765 586,199
Payments on long-term debt (128,364) (595,872)
Borrowings from revolving credit facility 83,000 78,244
Payments on revolving credit facility (93,028) (130,876)
Net cash overdraft financing 0 (1,261)
Deferred loan costs 0 (17,119)
Issuance of common stock 143 171
Repurchase of treasury stock (5,000) (5,912)
Minimum withholding taxes paid on stock awards (1,843) (4,838)
Distributions to noncontrolling interests (885) (2,820)
Net cash used by financing activities (117,212) (94,084)
Effect of exchange rate changes on cash (943) (299)
Net increase/(decrease) in cash and cash equivalents (8,299) 40,102
Cash and cash equivalents at beginning of period 156,884 108,784
Cash and cash equivalents at end of period 148,585 148,886
Supplemental disclosure of cash flow information:    
Accrued capital expenditures (3,302) 940
Cash paid during the period for:    
Interest, net of capitalized interest 62,395 57,764
Income taxes, net of refunds 14,018 4,005
Debt issued for assets 10 2,521
Contribution of assets to unconsolidated subsidiary $ 2,674 $ 0